Detalhe da pesquisa
1.
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.
HIV Clin Trials
; 17(2): 63-71, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27077673
2.
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.
Ann Hepatol
; 15(3): 333-49, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27049487
3.
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.
Gut
; 64(6): 948-56, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25080450
4.
STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection.
J Hepatol
; 62(6): 1246-55, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25559324
5.
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Gastroenterology
; 147(1): 132-142.e4, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24704719
6.
Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders.
J Hepatol
; 60(3): 490-9, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24444658
7.
Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial.
Hepatology
; 57(6): 2155-63, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23504636
8.
Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials.
Liver Int
; 34(5): 707-19, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24118703
9.
Boceprevir with peginterferon alfa-2a-ribavirin is effective for previously treated chronic hepatitis C genotype 1 infection.
Clin Gastroenterol Hepatol
; 11(1): 81-87.e4; quiz e5, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23064222
10.
How to optimize HCV therapy in genotype 1 patients with cirrhosis.
Liver Int
; 33 Suppl 1: 46-55, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23286846
11.
Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).
J Gastroenterol Hepatol
; 28(2): 329-34, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23190183
12.
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
N Engl J Med
; 360(18): 1839-50, 2009 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19403903
13.
Future treatment of patients with HCV cirrhosis.
Liver Int
; 32 Suppl 1: 113-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22212581
14.
Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver.
Liver Int
; 32(10): 1477-92, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22891751
15.
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection.
J Hepatol
; 54(6): 1114-22, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21145839
16.
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
N Engl J Med
; 357(22): 2227-36, 2007 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-18046027
17.
Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).
J Med Virol
; 82(12): 2027-31, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20981789
18.
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study.
Gastroenterol Clin Biol
; 31(2): 180-4, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17347628
19.
Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).
Patient
; 10(5): 605-614, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28353221
20.
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
Lancet Gastroenterol Hepatol
; 2(3): 177-188, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404133